Literature DB >> 16397208

Pancreatic cancer in mice and man: the Penn Workshop 2004.

Ralph H Hruban1, Anil K Rustgi, Teresa A Brentnall, Margaret A Tempero, Christopher V Wright, David A Tuveson.   

Abstract

A three-day conference cosponsored by the National Cancer Institute Mouse Models of Human Cancer Consortium and the Abramson Cancer Center of the University of Pennsylvania was convened on December 1, 2004, in Philadelphia, Pennsylvania. The purpose of the conference was to compare the histopathologic changes in murine models of exocrine pancreatic cancer to human disease and to discuss potential preclinical applications of these models. The participants of this international meeting included over 100 physicians and scientists with expertise in pancreatic cancer pathology, therapy, detection, and biology, and they were organized accordingly into working groups. The format of the meeting was a series of short presentations by individual participants followed by working group breakout sessions. The working groups presented their reports on the final day of the conference, and highlights of selected individual presentations and working group recommendations are summarized here and in an accompanying pathology consensus report.

Entities:  

Mesh:

Year:  2006        PMID: 16397208     DOI: 10.1158/0008-5472.CAN-05-3914

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  23 in total

1.  KRAS2 mutations in human pancreatic acinar-ductal metaplastic lesions are limited to those with PanIN: implications for the human pancreatic cancer cell of origin.

Authors:  Chanjuan Shi; Seung-Mo Hong; Phillip Lim; Hirohiko Kamiyama; Mehtab Khan; Robert A Anders; Michael Goggins; Ralph H Hruban; James R Eshleman
Journal:  Mol Cancer Res       Date:  2009-02-10       Impact factor: 5.852

2.  Bmi1 is required for the initiation of pancreatic cancer through an Ink4a-independent mechanism.

Authors:  Filip Bednar; Heather K Schofield; Meredith A Collins; Wei Yan; Yaqing Zhang; Nikhil Shyam; Jaime A Eberle; Luciana L Almada; Kenneth P Olive; Nabeel Bardeesy; Martin E Fernandez-Zapico; Daisuke Nakada; Diane M Simeone; Sean J Morrison; Marina Pasca di Magliano
Journal:  Carcinogenesis       Date:  2015-05-04       Impact factor: 4.944

3.  RAGE gene deletion inhibits the development and progression of ductal neoplasia and prolongs survival in a murine model of pancreatic cancer.

Authors:  Joseph DiNorcia; Minna K Lee; Dorota N Moroziewicz; Megan Winner; Paritosh Suman; Fei Bao; Helen E Remotti; Yu Shan Zou; Shi Fang Yan; Wanglong Qiu; Gloria H Su; Ann Marie Schmidt; John D Allendorf
Journal:  J Gastrointest Surg       Date:  2011-11-04       Impact factor: 3.452

4.  Sonic hedgehog acts at multiple stages during pancreatic tumorigenesis.

Authors:  Jennifer P Morton; Michelle E Mongeau; David S Klimstra; John P Morris; Yie Chia Lee; Yoshiya Kawaguchi; Christopher V E Wright; Matthias Hebrok; Brian C Lewis
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-19       Impact factor: 11.205

5.  Inhibition of chronic pancreatitis and pancreatic intraepithelial neoplasia (PanIN) by capsaicin in LSL-KrasG12D/Pdx1-Cre mice.

Authors:  Han Bai; Haonan Li; Wanying Zhang; Kristina A Matkowskyj; Jie Liao; Sanjay K Srivastava; Guang-Yu Yang
Journal:  Carcinogenesis       Date:  2011-08-22       Impact factor: 4.944

6.  A murine xenograft model of spontaneous metastases of human lung adenocarcinoma.

Authors:  James E Harris; James Shin; Beverly Lee; Kristen Pelosky; Craig M Hooker; Kirsten Harbom; Alicia Hulbert; Cynthia Zahnow; Stephen C Yang; Stephen Baylin; Cory Brayton; Malcolm V Brock
Journal:  J Surg Res       Date:  2011-07-22       Impact factor: 2.192

7.  Oncogenic Kras is required for both the initiation and maintenance of pancreatic cancer in mice.

Authors:  Meredith A Collins; Filip Bednar; Yaqing Zhang; Jean-Christophe Brisset; Stefanie Galbán; Craig J Galbán; Sabita Rakshit; Karen S Flannagan; N Volkan Adsay; Marina Pasca di Magliano
Journal:  J Clin Invest       Date:  2012-01-09       Impact factor: 14.808

Review 8.  Pancreatic cancer.

Authors:  Anirban Maitra; Ralph H Hruban
Journal:  Annu Rev Pathol       Date:  2008       Impact factor: 23.472

9.  Loss of Activin Receptor Type 1B Accelerates Development of Intraductal Papillary Mucinous Neoplasms in Mice With Activated KRAS.

Authors:  Wanglong Qiu; Sophia M Tang; Sohyae Lee; Andrew T Turk; Anthony N Sireci; Anne Qiu; Christian Rose; Chuangao Xie; Jan Kitajewski; Hui-Ju Wen; Howard C Crawford; Peter A Sims; Ralph H Hruban; Helen E Remotti; Gloria H Su
Journal:  Gastroenterology       Date:  2015-09-25       Impact factor: 22.682

Review 10.  KRAS, YAP, and obesity in pancreatic cancer: A signaling network with multiple loops.

Authors:  Guido Eibl; Enrique Rozengurt
Journal:  Semin Cancer Biol       Date:  2017-10-24       Impact factor: 15.707

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.